<DOC>
	<DOCNO>NCT01882088</DOCNO>
	<brief_summary>Gastroesophageal reflux disease ( GERD ) chronic condition , may significantly decrease patient ' quality life due typical symptom - heartburn regurgitation . These cause increase number transient low esophageal sphincter relaxation , regularly recur reflux gastric content oesophagus , acidification esophagus consequent esophageal mucosa damage . In addition , important role play increase production hydrochloric acid stomach , slowdown evacuation content stomach increase gastric intra-abdominal pressure . All factor may depend patient 's diet . Theoretical premise positive influence include dietary fiber course gastroesophageal reflux disease may fact dietary fiber may absorb nitric oxide ( NO ) contain food , turn relax effect low esophageal sphincter . In addition , fiber deficiency show associate increased chance develop hiatal hernia , associate great risk disease manifestation . There lack data diet modification enreaching dietary fiber type symptom frequency objective ( i.e . esophageal pH-impedance manometric ) parameter . MucofalkÂ® drug plant origin , consist shell seed Plantago ovata ( isphagula , psyllium ) . High content mucus composition psyllium seed allow include group soft food fiber , fundamental value appointment drug number disease , , example , use coarse food fibre recommend contraindicate . Mucofalk register medicinal ( registration number Russian State register medicine P N014176/01 , registration date 14.07.2008 , manufacturer : Lozan Pharma GmbH , packager : Dr. Falk Pharma GmbH , Germany ) . Recommended dosage administration : orally , adult child 12 year - 1 pack . 2-6 time day . Before use , content 1 packet pour glass , slowly pour cold water ( 150 ml ) , stir drink immediately . Then drink another glass liquid .</brief_summary>
	<brief_title>Phase IV Study Impact Dietary Fibers Symptoms Esophageal Motility Patients With Non-erosive GERD</brief_title>
	<detailed_description>During study 14-days screening period provide evaluate H.pylori endoscopic status patient confirm presence dietary fiber deficiency ( base standard computerized dietary questionnaire ) . On baseline physical examination , GERD-Q questionnaire , GERD symptom severity scale ( Likert ) , Bristol stool scale , high resolution esophageal manometry 24-hours esophageal pH-impedance study provide . Since baseline , day 10 Mucofalk 15 g/day TID regimen give . All patient receive standardize menu . Repeat evaluation symptom , high resolution esophageal manometry 24-hours esophagel pH-impedance do day 10 study .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<criteria>Clinical diagnosis nonerosive form Gastroesophageal Reflux disease Dietary fiber deficiency dietary questionnaire pathological gastroesophageal reflux 24hours esopageal pHimpedansometry willingness participate ( sign inform consent ) presence esophageal mucosal damage ( esophagitis ) endoscopic evaluation gastrointestinal surgery anamnesis current pregnancy breastfeed know hypersensitivity Mucofalk component</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>